PLANT TISSUE CULTURE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In July 2023, Merck, an multinational pharmaceutical company, announced the expansion of its facility in Lenexa, Kansas, U.S., adding 9,100 sq m2 of laboratory space and production capacity for manufacturing of cell culture media. According to Darren Verlenden, Head of Process Solutions Life Science at Merck, this expansion underscores its commitment to meeting global customer needs and growth plans.
• In January 2023, NuPlant, a biotechnology company, introduced SmartClone, an advanced plant tissue culture system enhancing breeding programs for multiple species. Using precision robotics, SmartClone produces robust clones from parent materials under customizable growth conditions, ensuring stronger, more uniform plantlets. This innovation aims to reduce labor and costs per plant significantly, catering to diverse applications in plant biotechnology.
• In January 2021, Scientists from Hokkaido University and Chiba University developed triploid and hexaploid varieties of Haemanthus albiflos using novel plant tissue culture techniques, specifically endosperm culture. This breakthrough not only enhances the ornamental appeal of the plant but also represents a pioneering use of endosperm culture for non-cereal monocot plants. The research findings were published in the Journal Plant Cell, Tissue and Organ Culture.